Discover the power of predictability with Fortrea for Biotech
We illuminate your journey of discovery with accountability, consistency and transparency. Committed to your mission TM
Anticipating challenges to mitigate risk and guide key decisions
Our biotech solutions are designed to promote predictability as we anticipate potential challenges, navigate clinical trial complexity and evolve with your needs, supporting you every step of the way.
Empowering accountability for biotech success
We’re dedicated to owning your success, matching your urgency and determination at every step. We ask the right questions so we can design biotech solutions with precision and purpose. Our approach builds clarity into every stage of your clinical trial, propelling you to reach your next milestone faster.
Delivering consistency for a predictable path ahead
We scale and flex with you as your plans evolve so you can expect stability while maintaining critical momentum across all phases of biotech development.
Video
We drive your progress with a biotech mindset
Reaching your next milestone and delivering your study within budget requires a proactive approach. Milestones matter, and you can’t afford to miss timelines. We empower our team through our Biotech Academy, providing a customer-centric perspective and the skillset to operate with agility, ownership and solution-focused thinking.
Building on our legacy forged from 30+ years of biotech-focused experience, we know how to enable accountability and transparency—helping you reach your next goal and owning your success at every step of the biotech journey.
Integrate regulatory, clinical, medical, market access and commercial strategies into your development
Streamline processes and reduce costs with our dedicated product development team. We create holistic approaches that combine cross-functional knowledge across all phases of your development program as our consultants extend and enhance your team’s expertise. Discover how we foster seamless collaboration between our teams and yours to find the fastest path for product development.
Access unmatched flexibility and scalability with Fortrea FSP (Functional Service Provider)
Our FSP delivery model provides continuity by seamlessly integrating scalable solutions across all phases of your study. Whether you need clinical operations, clinical data management, biostatistics and statistical programming or safety services and medical writing, our flexible, high-quality FSP collaborations are tailored to support the dynamic nature of biotech product development.
Fortrea Intelligent Technology: Elevate productivity with actionable insights
Fortrea Intelligent TechnologyTM can transform clinical trial operations by integrating AI-powered, persona-driven solutions that help automate workflows, streamline oversight and elevate productivity— enabling sponsors, investigator sites and Fortrea project teams to deliver trials faster, with greater predictability, agility and quality.
Fortrea for Biotech: Experience that matters
In the last 5 years, we have supported:
Biotech Portfolio Leads: Driving success together
Our Biotech Portfolio Leads (BPLs) embody Fortrea’s commitment to serving our emerging and established biotech customers with agility, accountability and collaboration. As seasoned operational leaders and portfolio-level advocates, they help biotech customers receive the strategic alignment and solution-focused delivery they require for predictable results.
Our BPL team blends deep industry and operational expertise with a hands-on approach to guide portfolios from proposal through delivery, achieve meaningful outcomes and enhance the customer experience.
Our comprehensive biotech solutions
Therapeutic Area Experience
Apply our decades of clinical development experience to make a difference in biotech clinical trials.
Clinical Pharmacology Services
Navigate the complexities of early phase biotech studies, as we anticipate risks and opportunities and apply data-driven insights.
Biotech Consulting
Access regulatory, product development and market access and HEOR solutions to enhance decision-making across the biotech journey.
Insights
Get the latest updates from our biotech team
Driving productivity in biotech clinical trials: How to maximize valuation for minimal cost
Read Driving productivity in biotech clinical trials: How to maximize valuation for minimal costBiotech Frequently Asked Questions
Driving innovation in biotech
-
What challenges do biotechs typically face?
Four main challenges include high industry competitiveness, scientific and technical uncertainty, limited funding and financial risk and building and managing the right team.
-
How competitive is the biotech industry?
Biotechs are racing to develop novel treatments using unproven science, facing rising development costs, crowded clinical trial markets and increasing pressure to produce meaningful data.
-
What risks do biotechs face in early stage development?
Early stage compounds often target areas with little existing data. A failed compound can be devastating since many emerging biotechs only have one or two assets in the pipeline. Missteps in site selection or trial execution can result in delays and financial setbacks.
-
How can biotechs address funding concerns?
Biotech products can take years to reach the market. This requires multiple funding rounds, each tied to development milestones. Biotechs need to meet their milestones to build investor trust and secure future funding.
-
How important is biotech project management?
Biotechs often have small teams and each individual plays a significant role. Leadership must maintain investor relationships and build a cohesive team aligned with strategic goals. They also need to decide what work stays in-house and what is outsourced to a CRO to extend the team’s expertise.
-
What’s the key to building an effective biotech development strategy?
Biotechs must plan early and align all activities with a defined end goal, such as regulatory approval or a key fundraising round. It’s essential to understand potential risks, consider all data requirements and develop a disciplined execution plan.
-
How are biotech clinical trials support through protocol design?
Biotechs should ensure their protocols are scientifically focused, operationally feasible, patient-centric and supported by appropriate data. It’s important to discuss development plans with regulatory authorities early, especially for advanced therapies, and consult subject matter experts to avoid costly missteps and align with evolving regulations.
-
How can working with a CRO (Contract Research Organization) enhance biotech solutions?
Biotech CROs bring scientific and regulatory experience, promote operational efficiencies, leverage global site and KOL (Key Opinion Leader) networks and develop strategic approaches in trial design and execution. They support biotech research and development, managing the complexities of drug development while allowing the biotech to focus on their core business and fundraising.
-
What is the outlook for biotech innovation?
Despite high risks and costs, biotechs are increasingly capable of taking drugs from discovery through commercialization—especially with strong strategic planning and the right support.